Cui-rong Zhao

发表

Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.

Zu-hua Gao, Xian-Jun Qu, Xiao-Fan Zhang, 2010, Cancer letters.

Original Article

W. Liu, Zu-hua Gao, Xian-Jun Qu, 2008 .

Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II

Zu-hua Gao, Xian-Jun Qu, H. Lou, 2012, Investigational New Drugs.

Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.

Xian-Jun Qu, H. Lou, B. Yue, 2012, Lung cancer.

Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.

Xian-Jun Qu, H. Lou, B. Yue, 2013, Cancer letters.

Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats

Xian-Jun Qu, Cui-rong Zhao, Ruiqi Wang, 2013, Cancer Chemotherapy and Pharmacology.

SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine.

Xian-Jun Qu, B. Yue, Cui-rong Zhao, 2012, Toxicology and applied pharmacology.

Inhibition of Intestinal Adenoma Formation in APCMin/ + Mice by Riccardin D, a Natural Product Derived from Liverwort Plant Dumortiera hirsuta

Zu-hua Gao, Xian-Jun Qu, H. Lou, 2012, PloS one.

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

Zu-hua Gao, Xian-Jun Qu, Xiao-Fan Zhang, 2011, Investigational new drugs.

Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.

Xian-Jun Qu, X. Xue, Wen-bao Li, 2013, Bioorganic & medicinal chemistry letters.

Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

Xian-Jun Qu, X. Xue, Cui-rong Zhao, 2012, Chemical biology & drug design.

Nrf2-ARE signaling pathway and natural products for cancer chemoprevention.

Zu-hua Gao, Xian-Jun Qu, Cui-rong Zhao, 2010, Cancer epidemiology.

Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.

Xian-Jun Qu, H. Lou, X. Xue, 2011, European journal of pharmacology.

A novel anticancer diarylurea derivative HL-40 as a multi-kinases inhibitor with good pharmacokinetics in Wistar rats.

Xian-Jun Qu, Wen-bao Li, Cui-rong Zhao, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Haishengsu, a Protein from Shellfish Tegillarca L. granosa, Inhibits the Growth and the Activity of Matrix Metalloproteinases-2 and -9 in Human Lung Carcinoma

Zu-hua Gao, Xian-Jun Qu, X. Xue, 2011 .

Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.

Zu-hua Gao, Xian-Jun Qu, N. Kokudo, 2011, European journal of cancer.

1082-39, an analogue of sorafenib, inhibited human cancer cell growth more potently than sorafenib.

Jia-Hui Chu, Xian-Jun Qu, Zhi-yu Song, 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

N3-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU

W. Liu, Zu-hua Gao, Xian-Jun Qu, 2009, Cancer Chemotherapy and Pharmacology.

Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.

Xian-Jun Qu, H. Lou, B. Yue, 2013, Biochimica et Biophysica Acta.